Literature DB >> 15122973

Effect of treatment with bupropion on EEG sleep: relationship to antidepressant response.

Geoffrey E Ott1, Uma Rao, Keh-Ming Lin, Lev Gertsik, Russell E Poland.   

Abstract

The objective of this study was to assess whether treatment with sustained-release bupropion (Wellbutrin-SR) produces alterations in electroencephalographic (EEG) sleep that are associated with clinical response to the drug. EEG sleep was measured in 20 patients with unipolar major depressive disorder before and after treatment with sustained-release bupropion. Each EEG sleep session consisted of two consecutive nights. Treatment with bupropion lasted for 8 wk. Compared to EEG sleep measures at baseline, treatment with bupropion significantly lengthened REM latency, increased REM activity and density during the first REM period, and increased total REM density. Differential response to treatment was associated with changes in REM activity and density, but not with REM latency. However, in contrast to many other antidepressants, REM sleep was not suppressed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122973     DOI: 10.1017/S1461145704004298

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  12 in total

Review 1.  Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

Authors:  Linda P Dwoskin; Anthony S Rauhut; Kelley A King-Pospisil; Michael T Bardo
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

2.  Antidepressant and Antipsychotic Drugs.

Authors:  Andrew D Krystal
Journal:  Sleep Med Clin       Date:  2010-12-01

3.  Clinical relevance of disturbances of sleep and vigilance in major depressive disorder: a review.

Authors:  Michael E Thase; Harald Murck; Anke Post
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

4.  An Unexpected Polysomnogram Finding.

Authors:  Brian N Palen; Lucas M Donovan; Elizabeth C Parsons
Journal:  J Clin Sleep Med       Date:  2016-11-15       Impact factor: 4.062

5.  Sleep architecture as correlate and predictor of symptoms and impairment in inter-episode bipolar disorder: taking on the challenge of medication effects.

Authors:  Polina Eidelman; Lisa S Talbot; June Gruber; Ilana Hairston; Allison G Harvey
Journal:  J Sleep Res       Date:  2010-12       Impact factor: 3.981

Review 6.  Antidepressants and sleep: a qualitative review of the literature.

Authors:  Sue Wilson; Spilios Argyropoulos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Bupropion response on sleep quality in patients with depression: implications for increased cardiovascular disease risk.

Authors:  Preetam J Schramm; Russell E Poland; Uma Rao
Journal:  Eur Neuropsychopharmacol       Date:  2013-10-11       Impact factor: 4.600

Review 8.  Insomnia in patients with depression: some pathophysiological and treatment considerations.

Authors:  Ripu D Jindal
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 9.  Bupropion: a review of its use in the management of major depressive disorder.

Authors:  Sohita Dhillon; Lily P H Yang; Monique P Curran
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Sleep and dreaming are for important matters.

Authors:  L Perogamvros; T T Dang-Vu; M Desseilles; S Schwartz
Journal:  Front Psychol       Date:  2013-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.